Search for: "Teva Pharmaceuticals USA Inc" Results 221 - 240 of 422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Sep 2009, 12:11 pm
USA, Inc., 395 F.3d 1364, 1372 (Fed. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
9 Apr 2010, 8:30 am by Lucas A. Ferrara, Esq.
Both products are manufactured by TEVA Pharmaceuticals USA in North Wales, Pa. [read post]
18 Jun 2018, 9:15 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
11 Dec 2008, 10:30 pm
(DRL); and Teva Pharmaceuticals USA, Inc. [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
5 Apr 2012, 1:41 pm by FDABlog HPM
Karst –       It was yet another exciting day in the Hatch-Waxman world when news broke Wednesday morning that Teva Pharmaceuticals USA, Inc. [read post]
13 Feb 2014, 8:36 am by m zamora
– topical gel applied to the skinAxiron (Lilly USA, LLC) – topical cream applied to underarmBio-T-Gel (Teva Pharmaceuticals) – topical gel applied to skinDelatestryl (Endo Pharmaceuticals) – injection or solutionDepo-Testosterone (Unigen Life Sciences) – injection solutionFortesta (Endo Pharmaceuticals) – topical gel applied to skinStriant (Auxilium Pharmaceuticals) – buccal… [read post]
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin… [read post]